Two Suits Added To OxyContin Antitrust Case
Two patent infringement suits have been added to the consolidated antitrust class action lawsuit filed over alleged inequitable conduct during the patent application process for the blockbuster painkiller OxyContin....To view the full article, register now.
Already a subscriber? Click here to view full article